image
Inhibikase Therapeutics, Inc. IKT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.05
-13.1 %
$ 138 M
Market Cap
-0.64
P/E
INCOME STATEMENT
260 K REVENUE
111.03%
Growth Rates
1Year 111.03%
3Years -28.02%
5Years -42.21%
7Years -17.09%
10Years 0.00%
-20.1 M OPERATING INCOME
-10.82%
Growth Rates
1Year -10.82%
3Years -92.45%
5Years -56.76%
7Years -64.62%
10Years 0.00%
-19 M NET INCOME
-5.40%
Growth Rates
1Year -5.40%
3Years -88.35%
5Years -54.63%
7Years -62.77%
10Years 0.00%
EFFICIENCY
Earnings Waterfall Inhibikase Therapeutics, Inc.
image
Revenue 260 K
Cost Of Revenue 13.6 M
Gross Profit -13.4 M
Operating Expenses 6.73 M
Operating Income -20.1 M
Other Expenses -1.06 M
Net Income -19 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
REVENUE
Revenue 0.3 0.1 3.1 0.7 1.1 4.0 2.1 1.0
GROSS PROFIT
Cost Of Revenue 13.6 6.72 K 11.4 0.9 2.6 3.6 1.8 0.8
Gross Profit (13.4) 0.1 (8.3) (0.2) (1.4) 0.4 0.3 0.1
OPERATING INCOME
Operating Expenses 6.7 18.1 14.8 2.8 5.7 2.1 2.5 0.7
Selling, General and Administrative Expenses 6.7 6.2 6.5 2.6 4.3 2.5 0.7 0.7
Research and Development Expenses 13.6 12.0 11.4 0.9 2.6 3.6 1.8 0.8
Operating Income (20.1) (18.1) (14.8) (2.8) (5.7) (2.1) (0.4) (0.6)
PRE-TAX INCOME
Interest Income Expense 0 74.5 K 19.9 K 29.4 K 24.8 K 30.3 K 0 0
Total Other Income 1.1 74.5 K 19.9 K 29.4 K 24.8 K 30.3 K 30.9 K 15.4 K
Pre-Tax Income (19.0) (18.1) (14.8) (2.8) (5.7) (2.2) (0.4) (0.6)
NET INCOME
Tax Provision 0 (0.1) 19.9 K 29.4 K 24.8 K (0.2) (0.4) 15.4 K
Net Income (19.0) (17.9) (14.8) (2.9) (5.7) (2.2) (0.4) (0.6)
EPS 3.57 4.26 4.88 1.72 3.34 1.61 0.25 0.48